The opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: A systematic review and meta-analysis
Chu Lin(Peking University), Linong Ji(Peking University), Suiyuan Hu(Peking University), Geling Liu(Tangshan Gongren Hospital), Wenjia Yang(Peking University), Fang Lv(Liaoning Normal University), Xiaolin Yang(Inner Mongolia Agricultural University), Xiaoling Cai(Peking University)
Cited by 16
Related Papers
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies
|Journal of Nanoparticle Research|2014|128
CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells
|Journal of Experimental & Clinical Cancer Research|2022|115